This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Appraisal of Long-Term Outcomes of Tricuspid Valve Replacement in the Current Perspective

Monday, March 21, 2016

Submitted by


Source Name: Annals of Thoracic Surgery


Amedeo Anselmi,MD, PhD, Vito Giovanni Ruggieri,MD, PhD,Majid Harmouche,MD, PhD, Erwan Flecher, MD, PhD, Herv  e Corbineau, MD, Thierry Langanay, MD,  Bernard Lelong, MD, Jean-Philippe Verhoye, MD, PhD, and Alain Leguerrier, MD

This French group retrospectively compared their experience with tricuspid valve replacements (n=188) using either tissue (82%) or mechanical (18%) valves during a >30-year period.  Findings from the study included:

  • Almost half the cases were reoperative surgeries, and concomitant procedures were performed in 71%.
  • Overall operative mortality was 28%, but decreased down to 10% in the most recent decade. 
  • Freedom from structural valve deterioration trended higher for mechanical valves but did not reach statistical significance.
  • Freedom from thromboembolic events and any valve-related adverse events were significantly higher for tissue valves.
  • Eleven patients required repeat tricuspid valve replacements for structural valve disease at a mean interval of 16 years (range 4 to 33 years).  None of these valves were mechanical at the original implantation.



Add comment

Log in or register to post comments